Fragment crystallizable region
Section of an antibody that interacts with cell surface receptors and some proteins of the complement system
The Fragment crystallizable region (Fc region) is a crucial part of an antibody that interacts with cell surface receptors and some proteins of the complement system. This region plays a significant role in the immune response by mediating various effector functions.
Structure
The Fc region is located at the tail end of the antibody molecule, opposite the antigen-binding fragment (Fab region). It is composed of two heavy chains that form a dimer, creating a Y-shaped structure. The Fc region is responsible for the antibody's ability to communicate with the immune system.
Function
The primary function of the Fc region is to bind to Fc receptors on the surface of various immune cells, such as macrophages, neutrophils, and natural killer cells. This binding triggers a range of immune responses, including:
- Phagocytosis: The process by which cells engulf and digest pathogens and debris.
- Antibody-dependent cellular cytotoxicity (ADCC): A mechanism through which immune cells can kill target cells that are coated with antibodies.
- Complement activation: The Fc region can initiate the complement cascade, leading to the lysis of pathogens.
Types of Fc Receptors
Fc receptors are classified based on the type of antibody they bind to. The main classes include:
- Fc_ receptors: Bind to IgG antibodies and are involved in phagocytosis and ADCC.
- Fc_ receptors: Bind to IgE antibodies and are involved in allergic responses.
- Fc_ receptors: Bind to IgA antibodies and play a role in mucosal immunity.
Clinical Significance
The interaction between the Fc region and Fc receptors is a target for therapeutic interventions. Monoclonal antibodies designed to treat various diseases often have modified Fc regions to enhance their efficacy or reduce adverse effects. For example, altering the glycosylation pattern of the Fc region can improve the antibody's ability to engage with Fc receptors.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD